BDBM471822 1-cyclopropyl-N-(4-(methylsulfonyl)benzyl)- 2-(((1r,4r)-4- (trifluoromethyl)cyclohexyl)methyl)-1H- benzo[d]imidazole-5-carboxamide::US10829448, Compound BE-30

SMILES CS(=O)(=O)c1ccc(CNC(=O)c2ccc3n(C4CC4)c(CC4CCC(CC4)C(F)(F)F)nc3c2)cc1

InChI Key InChIKey=ZVNBVUGXSUGHOV-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 471822   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Vitae Pharmaceuticals

US Patent
LigandPNGBDBM471822(1-cyclopropyl-N-(4-(methylsulfonyl)benzyl)- 2-(((1...)
Affinity DataKi: <100nMAssay Description:Compounds described herein were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-ligand (RL...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent